Available 24/7 (877) 245-6707

IVC Filter Maker, C.R. Bard, Might Have Known About Risks

Posted on March 23, 2016

Inferior vena cava filters (IVC filters) are tiny, spider-like devices that are inserted into the veins of blood clot-prone patients to prevent their clots from migrating into the heart or lungs. But IVC filters, which are implanted to save lives, have also been known to contribute to severe injuries, and even death. Almost thirty deaths nationwide have been attributed to IVC filters that have broken apart or migrated to different parts of the body. Many patients implanted with IVC filters have had them removed, but this is not always safely possible.

In late 2015, an NBC News investigation revealed evidence that one of the major manufacturers of IVC filters, New Jersey-based C.R. Bard, may have known that their devices were dangerous, but continued to sell them anyway. The investigation discovered internal company documents that showed some employees at C.R. Bard expressed concerns over the possible dangers of the IVC filter. C.R. Bard is no stranger to controversy. In the past, they’ve been fined for issuing illegal kickbacks to physicians and sued for injuries related to another of their products, vaginal mesh devices.

If you have had an IVC filter implanted, immediately consult your doctor. Once your health is secure, you need to contact a pharmaceutical litigation attorney. Companies that make prescription medications and medical devices have a duty to insure that their products are safe. Failure to do so is negligence and medical malpractice. A pharmaceutical injury claim can hold these companies legally responsible for their actions.

Anyone who has suffered injury or lost a loved one due to an IVC filter may be able to pursue compensation for personal injury, medical malpractice, or wrongful death. Farah & Farah is currently investigating IVC filter-related injuries and deaths nationwide.

To secure the settlement you deserve, call the law offices of Farah & Farah at (800) 533-3555 for a free consultation.